nodes	percent_of_prediction	percent_of_DWPC	metapath
Felodipine—CYP2C8—Vismodegib—skin cancer	0.0847	0.142	CbGbCtD
Felodipine—CYP2C9—Vismodegib—skin cancer	0.0591	0.0988	CbGbCtD
Felodipine—ABCB1—Vismodegib—skin cancer	0.0573	0.0959	CbGbCtD
Felodipine—CYP3A4—Temozolomide—skin cancer	0.0496	0.0829	CbGbCtD
Felodipine—CYP3A4—Imiquimod—skin cancer	0.0496	0.0829	CbGbCtD
Felodipine—CYP2D6—Vemurafenib—skin cancer	0.0427	0.0714	CbGbCtD
Felodipine—CYP3A4—Vismodegib—skin cancer	0.0344	0.0574	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0319	0.0533	CbGbCtD
Felodipine—CYP3A7—Docetaxel—skin cancer	0.0319	0.0533	CbGbCtD
Felodipine—ABCB1—Dactinomycin—skin cancer	0.0301	0.0504	CbGbCtD
Felodipine—CYP2C8—Fluorouracil—skin cancer	0.0301	0.0503	CbGbCtD
Felodipine—CYP3A4—Vemurafenib—skin cancer	0.0272	0.0454	CbGbCtD
Felodipine—CACNA1S—pes—skin cancer	0.0255	0.211	CbGeAlD
Felodipine—CYP3A5—Docetaxel—skin cancer	0.0239	0.04	CbGbCtD
Felodipine—CYP2C9—Fluorouracil—skin cancer	0.021	0.0351	CbGbCtD
Felodipine—ABCB1—Docetaxel—skin cancer	0.0156	0.026	CbGbCtD
Felodipine—CYP3A4—Docetaxel—skin cancer	0.00932	0.0156	CbGbCtD
Felodipine—CACNA1D—ear—skin cancer	0.00589	0.0488	CbGeAlD
Felodipine—TNNC2—connective tissue—skin cancer	0.00527	0.0436	CbGeAlD
Felodipine—CALM2—ear—skin cancer	0.00358	0.0296	CbGeAlD
Felodipine—CALM1—ear—skin cancer	0.00356	0.0295	CbGeAlD
Felodipine—CACNA2D2—neck—skin cancer	0.00311	0.0258	CbGeAlD
Felodipine—TNNC2—head—skin cancer	0.0031	0.0257	CbGeAlD
Felodipine—TNNC1—connective tissue—skin cancer	0.00265	0.022	CbGeAlD
Felodipine—CALM2—nerve—skin cancer	0.00225	0.0186	CbGeAlD
Felodipine—CALM1—nerve—skin cancer	0.00224	0.0186	CbGeAlD
Felodipine—TNNC2—lymph node—skin cancer	0.00217	0.018	CbGeAlD
Felodipine—PDE1B—female reproductive system—skin cancer	0.00195	0.0161	CbGeAlD
Felodipine—CALM2—endothelium—skin cancer	0.00192	0.0159	CbGeAlD
Felodipine—CALM1—endothelium—skin cancer	0.00191	0.0158	CbGeAlD
Felodipine—CALM2—hair follicle—skin cancer	0.00189	0.0156	CbGeAlD
Felodipine—NR3C2—nipple—skin cancer	0.00177	0.0147	CbGeAlD
Felodipine—CALM2—blood vessel—skin cancer	0.00177	0.0146	CbGeAlD
Felodipine—CALM1—blood vessel—skin cancer	0.00176	0.0146	CbGeAlD
Felodipine—PDE1A—female reproductive system—skin cancer	0.00164	0.0135	CbGeAlD
Felodipine—PDE1B—head—skin cancer	0.00163	0.0135	CbGeAlD
Felodipine—CALM3—nipple—skin cancer	0.00163	0.0135	CbGeAlD
Felodipine—CACNA1C—connective tissue—skin cancer	0.00138	0.0114	CbGeAlD
Felodipine—PDE1A—head—skin cancer	0.00137	0.0113	CbGeAlD
Felodipine—CACNA2D2—head—skin cancer	0.00131	0.0109	CbGeAlD
Felodipine—CALM2—nipple—skin cancer	0.00128	0.0106	CbGeAlD
Felodipine—CACNA1H—female reproductive system—skin cancer	0.00128	0.0106	CbGeAlD
Felodipine—CALM1—nipple—skin cancer	0.00127	0.0105	CbGeAlD
Felodipine—CALM2—neck—skin cancer	0.00127	0.0105	CbGeAlD
Felodipine—CALM1—neck—skin cancer	0.00126	0.0104	CbGeAlD
Felodipine—NR3C2—connective tissue—skin cancer	0.00126	0.0104	CbGeAlD
Felodipine—Upper respiratory tract infection—Imiquimod—skin cancer	0.00116	0.00669	CcSEcCtD
Felodipine—Influenza like illness—Temozolomide—skin cancer	0.00116	0.00667	CcSEcCtD
Felodipine—Oedema peripheral—Vemurafenib—skin cancer	0.00116	0.00665	CcSEcCtD
Felodipine—Constipation—Vismodegib—skin cancer	0.00116	0.00664	CcSEcCtD
Felodipine—Erectile dysfunction—Imiquimod—skin cancer	0.00115	0.00663	CcSEcCtD
Felodipine—Photosensitivity reaction—Imiquimod—skin cancer	0.00114	0.00657	CcSEcCtD
Felodipine—PDE1B—lymph node—skin cancer	0.00114	0.00945	CbGeAlD
Felodipine—Erythema multiforme—Vemurafenib—skin cancer	0.00111	0.00638	CcSEcCtD
Felodipine—Gastrointestinal pain—Vismodegib—skin cancer	0.00111	0.00635	CcSEcCtD
Felodipine—TNNC1—lymph node—skin cancer	0.00109	0.00906	CbGeAlD
Felodipine—Abdominal pain—Vismodegib—skin cancer	0.00107	0.00614	CcSEcCtD
Felodipine—Cerebrovascular accident—Bleomycin—skin cancer	0.00105	0.00603	CcSEcCtD
Felodipine—Sinusitis—Imiquimod—skin cancer	0.00105	0.00602	CcSEcCtD
Felodipine—NR3C2—mammalian vulva—skin cancer	0.00103	0.00856	CbGeAlD
Felodipine—Erythema—Vemurafenib—skin cancer	0.00102	0.00588	CcSEcCtD
Felodipine—CACNB2—head—skin cancer	0.00101	0.00834	CbGeAlD
Felodipine—Pharyngitis—Imiquimod—skin cancer	0.000995	0.00571	CcSEcCtD
Felodipine—Back pain—Vemurafenib—skin cancer	0.00099	0.00569	CcSEcCtD
Felodipine—Rhinorrhoea—Docetaxel—skin cancer	0.000982	0.00564	CcSEcCtD
Felodipine—CACNA1C—female reproductive system—skin cancer	0.000973	0.00805	CbGeAlD
Felodipine—Asthenia—Vismodegib—skin cancer	0.00097	0.00557	CcSEcCtD
Felodipine—Visual impairment—Imiquimod—skin cancer	0.000966	0.00555	CcSEcCtD
Felodipine—Pruritus—Vismodegib—skin cancer	0.000956	0.00549	CcSEcCtD
Felodipine—PDE1A—lymph node—skin cancer	0.000956	0.00792	CbGeAlD
Felodipine—CALM3—mammalian vulva—skin cancer	0.000951	0.00787	CbGeAlD
Felodipine—Erythema multiforme—Imiquimod—skin cancer	0.000948	0.00544	CcSEcCtD
Felodipine—CACNA2D1—head—skin cancer	0.000946	0.00783	CbGeAlD
Felodipine—Flushing—Imiquimod—skin cancer	0.00093	0.00534	CcSEcCtD
Felodipine—Diarrhoea—Vismodegib—skin cancer	0.000925	0.00531	CcSEcCtD
Felodipine—CACNA2D2—lymph node—skin cancer	0.000921	0.00762	CbGeAlD
Felodipine—CALM2—connective tissue—skin cancer	0.000907	0.00751	CbGeAlD
Felodipine—Swelling—Fluorouracil—skin cancer	0.000907	0.00521	CcSEcCtD
Felodipine—CALM1—connective tissue—skin cancer	0.000903	0.00747	CbGeAlD
Felodipine—Arrhythmia—Imiquimod—skin cancer	0.000896	0.00514	CcSEcCtD
Felodipine—Cough—Vemurafenib—skin cancer	0.000893	0.00513	CcSEcCtD
Felodipine—NR3C2—female reproductive system—skin cancer	0.000885	0.00733	CbGeAlD
Felodipine—CACNA1D—head—skin cancer	0.00088	0.00729	CbGeAlD
Felodipine—Erythema—Imiquimod—skin cancer	0.000873	0.00501	CcSEcCtD
Felodipine—Arthralgia—Vemurafenib—skin cancer	0.000871	0.005	CcSEcCtD
Felodipine—Myalgia—Vemurafenib—skin cancer	0.000871	0.005	CcSEcCtD
Felodipine—CALM2—epithelium—skin cancer	0.000861	0.00713	CbGeAlD
Felodipine—Vomiting—Vismodegib—skin cancer	0.00086	0.00494	CcSEcCtD
Felodipine—CALM1—epithelium—skin cancer	0.000857	0.0071	CbGeAlD
Felodipine—Rash—Vismodegib—skin cancer	0.000852	0.0049	CcSEcCtD
Felodipine—Dermatitis—Vismodegib—skin cancer	0.000852	0.00489	CcSEcCtD
Felodipine—Back pain—Imiquimod—skin cancer	0.000844	0.00485	CcSEcCtD
Felodipine—Face oedema—Temozolomide—skin cancer	0.000838	0.00482	CcSEcCtD
Felodipine—CALM2—skin of body—skin cancer	0.000819	0.00678	CbGeAlD
Felodipine—CALM1—skin of body—skin cancer	0.000815	0.00675	CbGeAlD
Felodipine—CACNA1C—head—skin cancer	0.000813	0.00673	CbGeAlD
Felodipine—Nausea—Vismodegib—skin cancer	0.000803	0.00461	CcSEcCtD
Felodipine—Angioedema—Imiquimod—skin cancer	0.000797	0.00458	CcSEcCtD
Felodipine—Syncope—Imiquimod—skin cancer	0.000783	0.00449	CcSEcCtD
Felodipine—Influenza like illness—Docetaxel—skin cancer	0.000773	0.00444	CcSEcCtD
Felodipine—Palpitations—Imiquimod—skin cancer	0.000771	0.00443	CcSEcCtD
Felodipine—Loss of consciousness—Imiquimod—skin cancer	0.000767	0.00441	CcSEcCtD
Felodipine—Irritability—Fluorouracil—skin cancer	0.000764	0.00439	CcSEcCtD
Felodipine—Cough—Imiquimod—skin cancer	0.000762	0.00437	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000761	0.00437	CcSEcCtD
Felodipine—CALM2—mammalian vulva—skin cancer	0.000747	0.00618	CbGeAlD
Felodipine—CACNA1H—lymph node—skin cancer	0.000747	0.00618	CbGeAlD
Felodipine—CALM1—mammalian vulva—skin cancer	0.000744	0.00615	CbGeAlD
Felodipine—Myalgia—Imiquimod—skin cancer	0.000743	0.00427	CcSEcCtD
Felodipine—Chest pain—Imiquimod—skin cancer	0.000743	0.00427	CcSEcCtD
Felodipine—Arthralgia—Imiquimod—skin cancer	0.000743	0.00427	CcSEcCtD
Felodipine—NR3C2—head—skin cancer	0.00074	0.00612	CbGeAlD
Felodipine—Dry mouth—Imiquimod—skin cancer	0.000727	0.00417	CcSEcCtD
Felodipine—Bronchitis—Temozolomide—skin cancer	0.000722	0.00415	CcSEcCtD
Felodipine—Fatigue—Vemurafenib—skin cancer	0.00072	0.00414	CcSEcCtD
Felodipine—Nasopharyngitis—Fluorouracil—skin cancer	0.000716	0.00411	CcSEcCtD
Felodipine—Constipation—Vemurafenib—skin cancer	0.000714	0.0041	CcSEcCtD
Felodipine—CACNB2—lymph node—skin cancer	0.000705	0.00584	CbGeAlD
Felodipine—ABCB1—blood vessel—skin cancer	0.000703	0.00582	CbGeAlD
Felodipine—Dysuria—Temozolomide—skin cancer	0.000702	0.00403	CcSEcCtD
Felodipine—Shock—Imiquimod—skin cancer	0.000701	0.00402	CcSEcCtD
Felodipine—Upper respiratory tract infection—Temozolomide—skin cancer	0.000698	0.00401	CcSEcCtD
Felodipine—Tachycardia—Imiquimod—skin cancer	0.000695	0.00399	CcSEcCtD
Felodipine—Pollakiuria—Temozolomide—skin cancer	0.000693	0.00398	CcSEcCtD
Felodipine—Erectile dysfunction—Temozolomide—skin cancer	0.000691	0.00397	CcSEcCtD
Felodipine—Photosensitivity reaction—Temozolomide—skin cancer	0.000685	0.00393	CcSEcCtD
Felodipine—Angina pectoris—Fluorouracil—skin cancer	0.000674	0.00387	CcSEcCtD
Felodipine—CALM2—lymphoid tissue—skin cancer	0.000663	0.00549	CbGeAlD
Felodipine—CACNA2D1—lymph node—skin cancer	0.000662	0.00548	CbGeAlD
Felodipine—Flushing—Bleomycin—skin cancer	0.000661	0.0038	CcSEcCtD
Felodipine—Body temperature increased—Vemurafenib—skin cancer	0.00066	0.00379	CcSEcCtD
Felodipine—CALM1—lymphoid tissue—skin cancer	0.00066	0.00546	CbGeAlD
Felodipine—Pharyngitis—Dactinomycin—skin cancer	0.000659	0.00379	CcSEcCtD
Felodipine—Swelling—Docetaxel—skin cancer	0.000655	0.00376	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000649	0.00373	CcSEcCtD
Felodipine—Insomnia—Imiquimod—skin cancer	0.000644	0.0037	CcSEcCtD
Felodipine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000643	0.00369	CcSEcCtD
Felodipine—CALM2—female reproductive system—skin cancer	0.00064	0.0053	CbGeAlD
Felodipine—Paraesthesia—Imiquimod—skin cancer	0.00064	0.00367	CcSEcCtD
Felodipine—CALM1—female reproductive system—skin cancer	0.000637	0.00527	CbGeAlD
Felodipine—Dyspnoea—Imiquimod—skin cancer	0.000635	0.00365	CcSEcCtD
Felodipine—Somnolence—Imiquimod—skin cancer	0.000633	0.00364	CcSEcCtD
Felodipine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000631	0.00363	CcSEcCtD
Felodipine—Erythema multiforme—Dactinomycin—skin cancer	0.000628	0.00361	CcSEcCtD
Felodipine—Sinusitis—Temozolomide—skin cancer	0.000628	0.00361	CcSEcCtD
Felodipine—Dyspepsia—Imiquimod—skin cancer	0.000627	0.0036	CcSEcCtD
Felodipine—Erythema—Bleomycin—skin cancer	0.00062	0.00356	CcSEcCtD
Felodipine—Flushing—Dactinomycin—skin cancer	0.000617	0.00354	CcSEcCtD
Felodipine—CACNA1D—lymph node—skin cancer	0.000616	0.0051	CbGeAlD
Felodipine—Hypersensitivity—Vemurafenib—skin cancer	0.000615	0.00353	CcSEcCtD
Felodipine—Fatigue—Imiquimod—skin cancer	0.000614	0.00353	CcSEcCtD
Felodipine—Visual disturbance—Docetaxel—skin cancer	0.000609	0.0035	CcSEcCtD
Felodipine—Asthenia—Vemurafenib—skin cancer	0.000599	0.00344	CcSEcCtD
Felodipine—Pharyngitis—Temozolomide—skin cancer	0.000596	0.00342	CcSEcCtD
Felodipine—Oedema peripheral—Temozolomide—skin cancer	0.000592	0.0034	CcSEcCtD
Felodipine—Pruritus—Vemurafenib—skin cancer	0.000591	0.00339	CcSEcCtD
Felodipine—Feeling abnormal—Imiquimod—skin cancer	0.000587	0.00337	CcSEcCtD
Felodipine—Gastrointestinal pain—Imiquimod—skin cancer	0.000582	0.00335	CcSEcCtD
Felodipine—Epistaxis—Fluorouracil—skin cancer	0.000582	0.00334	CcSEcCtD
Felodipine—Visual impairment—Temozolomide—skin cancer	0.000579	0.00333	CcSEcCtD
Felodipine—Sinusitis—Fluorouracil—skin cancer	0.000579	0.00332	CcSEcCtD
Felodipine—Erythema—Dactinomycin—skin cancer	0.000578	0.00332	CcSEcCtD
Felodipine—Pain in extremity—Docetaxel—skin cancer	0.000578	0.00332	CcSEcCtD
Felodipine—Anaemia—Bleomycin—skin cancer	0.000573	0.00329	CcSEcCtD
Felodipine—Diarrhoea—Vemurafenib—skin cancer	0.000571	0.00328	CcSEcCtD
Felodipine—CACNA1C—lymph node—skin cancer	0.000569	0.00471	CbGeAlD
Felodipine—Erythema multiforme—Temozolomide—skin cancer	0.000568	0.00326	CcSEcCtD
Felodipine—Urticaria—Imiquimod—skin cancer	0.000566	0.00325	CcSEcCtD
Felodipine—Abdominal pain—Imiquimod—skin cancer	0.000563	0.00323	CcSEcCtD
Felodipine—Body temperature increased—Imiquimod—skin cancer	0.000563	0.00323	CcSEcCtD
Felodipine—Flushing—Temozolomide—skin cancer	0.000558	0.0032	CcSEcCtD
Felodipine—Dizziness—Vemurafenib—skin cancer	0.000552	0.00317	CcSEcCtD
Felodipine—Pharyngitis—Fluorouracil—skin cancer	0.000549	0.00316	CcSEcCtD
Felodipine—Cough—Bleomycin—skin cancer	0.000541	0.00311	CcSEcCtD
Felodipine—Anaemia—Dactinomycin—skin cancer	0.000534	0.00307	CcSEcCtD
Felodipine—CALM2—head—skin cancer	0.000534	0.00442	CbGeAlD
Felodipine—CALM1—head—skin cancer	0.000532	0.0044	CbGeAlD
Felodipine—Vomiting—Vemurafenib—skin cancer	0.000531	0.00305	CcSEcCtD
Felodipine—CYP2C8—female reproductive system—skin cancer	0.00053	0.00439	CbGeAlD
Felodipine—Chest pain—Bleomycin—skin cancer	0.000528	0.00303	CcSEcCtD
Felodipine—Myalgia—Bleomycin—skin cancer	0.000528	0.00303	CcSEcCtD
Felodipine—Orthostatic hypotension—Docetaxel—skin cancer	0.000528	0.00303	CcSEcCtD
Felodipine—Rash—Vemurafenib—skin cancer	0.000527	0.00302	CcSEcCtD
Felodipine—Dermatitis—Vemurafenib—skin cancer	0.000526	0.00302	CcSEcCtD
Felodipine—Hypersensitivity—Imiquimod—skin cancer	0.000525	0.00301	CcSEcCtD
Felodipine—Headache—Vemurafenib—skin cancer	0.000523	0.003	CcSEcCtD
Felodipine—Erythema—Temozolomide—skin cancer	0.000523	0.003	CcSEcCtD
Felodipine—Cramp muscle—Docetaxel—skin cancer	0.00052	0.00299	CcSEcCtD
Felodipine—NR3C2—lymph node—skin cancer	0.000518	0.00429	CbGeAlD
Felodipine—Nasopharyngitis—Docetaxel—skin cancer	0.000516	0.00297	CcSEcCtD
Felodipine—Asthenia—Imiquimod—skin cancer	0.000511	0.00293	CcSEcCtD
Felodipine—Confusional state—Bleomycin—skin cancer	0.00051	0.00293	CcSEcCtD
Felodipine—Back pain—Temozolomide—skin cancer	0.000506	0.00291	CcSEcCtD
Felodipine—Pruritus—Imiquimod—skin cancer	0.000504	0.00289	CcSEcCtD
Felodipine—Nausea—Vemurafenib—skin cancer	0.000496	0.00285	CcSEcCtD
Felodipine—Arrhythmia—Fluorouracil—skin cancer	0.000495	0.00284	CcSEcCtD
Felodipine—Myalgia—Dactinomycin—skin cancer	0.000492	0.00283	CcSEcCtD
Felodipine—Tremor—Temozolomide—skin cancer	0.00049	0.00281	CcSEcCtD
Felodipine—Diarrhoea—Imiquimod—skin cancer	0.000487	0.0028	CcSEcCtD
Felodipine—Angina pectoris—Docetaxel—skin cancer	0.000486	0.00279	CcSEcCtD
Felodipine—Anaemia—Temozolomide—skin cancer	0.000483	0.00278	CcSEcCtD
Felodipine—Erythema—Fluorouracil—skin cancer	0.000482	0.00277	CcSEcCtD
Felodipine—Angioedema—Temozolomide—skin cancer	0.000478	0.00274	CcSEcCtD
Felodipine—CALM3—lymph node—skin cancer	0.000477	0.00394	CbGeAlD
Felodipine—Dizziness—Imiquimod—skin cancer	0.000471	0.00271	CcSEcCtD
Felodipine—CYP2C9—female reproductive system—skin cancer	0.000471	0.0039	CbGeAlD
Felodipine—Vertigo—Temozolomide—skin cancer	0.00047	0.0027	CcSEcCtD
Felodipine—Palpitations—Temozolomide—skin cancer	0.000462	0.00265	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000461	0.00265	CcSEcCtD
Felodipine—Cough—Temozolomide—skin cancer	0.000456	0.00262	CcSEcCtD
Felodipine—Paraesthesia—Bleomycin—skin cancer	0.000454	0.00261	CcSEcCtD
Felodipine—Vomiting—Imiquimod—skin cancer	0.000453	0.0026	CcSEcCtD
Felodipine—Dyspnoea—Bleomycin—skin cancer	0.000451	0.00259	CcSEcCtD
Felodipine—Rash—Imiquimod—skin cancer	0.000449	0.00258	CcSEcCtD
Felodipine—Dermatitis—Imiquimod—skin cancer	0.000449	0.00258	CcSEcCtD
Felodipine—Headache—Imiquimod—skin cancer	0.000446	0.00256	CcSEcCtD
Felodipine—Anaemia—Fluorouracil—skin cancer	0.000445	0.00256	CcSEcCtD
Felodipine—Myalgia—Temozolomide—skin cancer	0.000445	0.00256	CcSEcCtD
Felodipine—Arthralgia—Temozolomide—skin cancer	0.000445	0.00256	CcSEcCtD
Felodipine—Dry mouth—Temozolomide—skin cancer	0.000435	0.0025	CcSEcCtD
Felodipine—Confusional state—Temozolomide—skin cancer	0.00043	0.00247	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00043	0.00247	CcSEcCtD
Felodipine—Nausea—Imiquimod—skin cancer	0.000423	0.00243	CcSEcCtD
Felodipine—Epistaxis—Docetaxel—skin cancer	0.00042	0.00241	CcSEcCtD
Felodipine—Feeling abnormal—Bleomycin—skin cancer	0.000417	0.00239	CcSEcCtD
Felodipine—Myalgia—Fluorouracil—skin cancer	0.00041	0.00236	CcSEcCtD
Felodipine—Chest pain—Fluorouracil—skin cancer	0.00041	0.00236	CcSEcCtD
Felodipine—Fatigue—Dactinomycin—skin cancer	0.000407	0.00234	CcSEcCtD
Felodipine—Urticaria—Bleomycin—skin cancer	0.000402	0.00231	CcSEcCtD
Felodipine—Body temperature increased—Bleomycin—skin cancer	0.0004	0.0023	CcSEcCtD
Felodipine—Confusional state—Fluorouracil—skin cancer	0.000397	0.00228	CcSEcCtD
Felodipine—Pharyngitis—Docetaxel—skin cancer	0.000397	0.00228	CcSEcCtD
Felodipine—Oedema peripheral—Docetaxel—skin cancer	0.000394	0.00226	CcSEcCtD
Felodipine—Feeling abnormal—Dactinomycin—skin cancer	0.000389	0.00223	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000389	0.00223	CcSEcCtD
Felodipine—Insomnia—Temozolomide—skin cancer	0.000386	0.00222	CcSEcCtD
Felodipine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000386	0.00222	CcSEcCtD
Felodipine—Visual impairment—Docetaxel—skin cancer	0.000385	0.00221	CcSEcCtD
Felodipine—Tachycardia—Fluorouracil—skin cancer	0.000384	0.0022	CcSEcCtD
Felodipine—Paraesthesia—Temozolomide—skin cancer	0.000383	0.0022	CcSEcCtD
Felodipine—Dyspnoea—Temozolomide—skin cancer	0.000381	0.00219	CcSEcCtD
Felodipine—Somnolence—Temozolomide—skin cancer	0.000379	0.00218	CcSEcCtD
Felodipine—Erythema multiforme—Docetaxel—skin cancer	0.000378	0.00217	CcSEcCtD
Felodipine—Dyspepsia—Temozolomide—skin cancer	0.000376	0.00216	CcSEcCtD
Felodipine—CALM2—lymph node—skin cancer	0.000374	0.0031	CbGeAlD
Felodipine—Abdominal pain—Dactinomycin—skin cancer	0.000373	0.00214	CcSEcCtD
Felodipine—Body temperature increased—Dactinomycin—skin cancer	0.000373	0.00214	CcSEcCtD
Felodipine—Hypersensitivity—Bleomycin—skin cancer	0.000373	0.00214	CcSEcCtD
Felodipine—CALM1—lymph node—skin cancer	0.000373	0.00308	CbGeAlD
Felodipine—Flushing—Docetaxel—skin cancer	0.000371	0.00213	CcSEcCtD
Felodipine—Fatigue—Temozolomide—skin cancer	0.000368	0.00211	CcSEcCtD
Felodipine—Constipation—Temozolomide—skin cancer	0.000365	0.0021	CcSEcCtD
Felodipine—Asthenia—Bleomycin—skin cancer	0.000363	0.00209	CcSEcCtD
Felodipine—CYP3A4—female reproductive system—skin cancer	0.000359	0.00297	CbGeAlD
Felodipine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000358	0.00206	CcSEcCtD
Felodipine—Pruritus—Bleomycin—skin cancer	0.000358	0.00206	CcSEcCtD
Felodipine—Arrhythmia—Docetaxel—skin cancer	0.000357	0.00205	CcSEcCtD
Felodipine—Insomnia—Fluorouracil—skin cancer	0.000356	0.00204	CcSEcCtD
Felodipine—CYP2D6—female reproductive system—skin cancer	0.000353	0.00293	CbGeAlD
Felodipine—Paraesthesia—Fluorouracil—skin cancer	0.000353	0.00203	CcSEcCtD
Felodipine—Feeling abnormal—Temozolomide—skin cancer	0.000352	0.00202	CcSEcCtD
Felodipine—Dyspnoea—Fluorouracil—skin cancer	0.000351	0.00201	CcSEcCtD
Felodipine—Somnolence—Fluorouracil—skin cancer	0.00035	0.00201	CcSEcCtD
Felodipine—Gastrointestinal pain—Temozolomide—skin cancer	0.000349	0.002	CcSEcCtD
Felodipine—Erythema—Docetaxel—skin cancer	0.000348	0.002	CcSEcCtD
Felodipine—Hypersensitivity—Dactinomycin—skin cancer	0.000348	0.002	CcSEcCtD
Felodipine—Dyspepsia—Fluorouracil—skin cancer	0.000346	0.00199	CcSEcCtD
Felodipine—ABCB1—epithelium—skin cancer	0.000342	0.00283	CbGeAlD
Felodipine—Urticaria—Temozolomide—skin cancer	0.000339	0.00195	CcSEcCtD
Felodipine—Asthenia—Dactinomycin—skin cancer	0.000339	0.00194	CcSEcCtD
Felodipine—Abdominal pain—Temozolomide—skin cancer	0.000337	0.00194	CcSEcCtD
Felodipine—Body temperature increased—Temozolomide—skin cancer	0.000337	0.00194	CcSEcCtD
Felodipine—Back pain—Docetaxel—skin cancer	0.000336	0.00193	CcSEcCtD
Felodipine—Muscle spasms—Docetaxel—skin cancer	0.000334	0.00192	CcSEcCtD
Felodipine—Feeling abnormal—Fluorouracil—skin cancer	0.000324	0.00186	CcSEcCtD
Felodipine—Diarrhoea—Dactinomycin—skin cancer	0.000323	0.00185	CcSEcCtD
Felodipine—Vomiting—Bleomycin—skin cancer	0.000322	0.00185	CcSEcCtD
Felodipine—Anaemia—Docetaxel—skin cancer	0.000321	0.00185	CcSEcCtD
Felodipine—Rash—Bleomycin—skin cancer	0.000319	0.00183	CcSEcCtD
Felodipine—Dermatitis—Bleomycin—skin cancer	0.000319	0.00183	CcSEcCtD
Felodipine—Hypersensitivity—Temozolomide—skin cancer	0.000314	0.00181	CcSEcCtD
Felodipine—Urticaria—Fluorouracil—skin cancer	0.000312	0.00179	CcSEcCtD
Felodipine—Syncope—Docetaxel—skin cancer	0.000312	0.00179	CcSEcCtD
Felodipine—Body temperature increased—Fluorouracil—skin cancer	0.000311	0.00179	CcSEcCtD
Felodipine—Palpitations—Docetaxel—skin cancer	0.000307	0.00177	CcSEcCtD
Felodipine—Asthenia—Temozolomide—skin cancer	0.000306	0.00176	CcSEcCtD
Felodipine—Loss of consciousness—Docetaxel—skin cancer	0.000306	0.00176	CcSEcCtD
Felodipine—Cough—Docetaxel—skin cancer	0.000304	0.00174	CcSEcCtD
Felodipine—Pruritus—Temozolomide—skin cancer	0.000302	0.00173	CcSEcCtD
Felodipine—Nausea—Bleomycin—skin cancer	0.000301	0.00173	CcSEcCtD
Felodipine—Vomiting—Dactinomycin—skin cancer	0.0003	0.00172	CcSEcCtD
Felodipine—Rash—Dactinomycin—skin cancer	0.000298	0.00171	CcSEcCtD
Felodipine—ABCB1—mammalian vulva—skin cancer	0.000297	0.00246	CbGeAlD
Felodipine—Arthralgia—Docetaxel—skin cancer	0.000296	0.0017	CcSEcCtD
Felodipine—Chest pain—Docetaxel—skin cancer	0.000296	0.0017	CcSEcCtD
Felodipine—Myalgia—Docetaxel—skin cancer	0.000296	0.0017	CcSEcCtD
Felodipine—CYP2D6—head—skin cancer	0.000295	0.00244	CbGeAlD
Felodipine—Diarrhoea—Temozolomide—skin cancer	0.000292	0.00168	CcSEcCtD
Felodipine—Hypersensitivity—Fluorouracil—skin cancer	0.00029	0.00166	CcSEcCtD
Felodipine—Dry mouth—Docetaxel—skin cancer	0.00029	0.00166	CcSEcCtD
Felodipine—Confusional state—Docetaxel—skin cancer	0.000286	0.00164	CcSEcCtD
Felodipine—Dizziness—Temozolomide—skin cancer	0.000282	0.00162	CcSEcCtD
Felodipine—Nausea—Dactinomycin—skin cancer	0.00028	0.00161	CcSEcCtD
Felodipine—Shock—Docetaxel—skin cancer	0.000279	0.0016	CcSEcCtD
Felodipine—Pruritus—Fluorouracil—skin cancer	0.000278	0.0016	CcSEcCtD
Felodipine—Tachycardia—Docetaxel—skin cancer	0.000277	0.00159	CcSEcCtD
Felodipine—Vomiting—Temozolomide—skin cancer	0.000271	0.00156	CcSEcCtD
Felodipine—Rash—Temozolomide—skin cancer	0.000269	0.00155	CcSEcCtD
Felodipine—Diarrhoea—Fluorouracil—skin cancer	0.000269	0.00155	CcSEcCtD
Felodipine—Dermatitis—Temozolomide—skin cancer	0.000269	0.00154	CcSEcCtD
Felodipine—Headache—Temozolomide—skin cancer	0.000267	0.00154	CcSEcCtD
Felodipine—ABCB1—lymphoid tissue—skin cancer	0.000264	0.00218	CbGeAlD
Felodipine—Dizziness—Fluorouracil—skin cancer	0.00026	0.00149	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000259	0.00149	CcSEcCtD
Felodipine—Insomnia—Docetaxel—skin cancer	0.000257	0.00147	CcSEcCtD
Felodipine—Paraesthesia—Docetaxel—skin cancer	0.000255	0.00146	CcSEcCtD
Felodipine—ABCB1—female reproductive system—skin cancer	0.000254	0.0021	CbGeAlD
Felodipine—Nausea—Temozolomide—skin cancer	0.000254	0.00146	CcSEcCtD
Felodipine—Dyspnoea—Docetaxel—skin cancer	0.000253	0.00145	CcSEcCtD
Felodipine—Somnolence—Docetaxel—skin cancer	0.000252	0.00145	CcSEcCtD
Felodipine—Vomiting—Fluorouracil—skin cancer	0.00025	0.00144	CcSEcCtD
Felodipine—Dyspepsia—Docetaxel—skin cancer	0.00025	0.00144	CcSEcCtD
Felodipine—Rash—Fluorouracil—skin cancer	0.000248	0.00142	CcSEcCtD
Felodipine—Dermatitis—Fluorouracil—skin cancer	0.000248	0.00142	CcSEcCtD
Felodipine—Headache—Fluorouracil—skin cancer	0.000246	0.00141	CcSEcCtD
Felodipine—Fatigue—Docetaxel—skin cancer	0.000245	0.00141	CcSEcCtD
Felodipine—Constipation—Docetaxel—skin cancer	0.000243	0.00139	CcSEcCtD
Felodipine—Feeling abnormal—Docetaxel—skin cancer	0.000234	0.00134	CcSEcCtD
Felodipine—Nausea—Fluorouracil—skin cancer	0.000234	0.00134	CcSEcCtD
Felodipine—Gastrointestinal pain—Docetaxel—skin cancer	0.000232	0.00133	CcSEcCtD
Felodipine—Abdominal pain—Docetaxel—skin cancer	0.000224	0.00129	CcSEcCtD
Felodipine—Body temperature increased—Docetaxel—skin cancer	0.000224	0.00129	CcSEcCtD
Felodipine—ABCB1—head—skin cancer	0.000212	0.00176	CbGeAlD
Felodipine—Hypersensitivity—Docetaxel—skin cancer	0.000209	0.0012	CcSEcCtD
Felodipine—Asthenia—Docetaxel—skin cancer	0.000204	0.00117	CcSEcCtD
Felodipine—Pruritus—Docetaxel—skin cancer	0.000201	0.00115	CcSEcCtD
Felodipine—Diarrhoea—Docetaxel—skin cancer	0.000194	0.00112	CcSEcCtD
Felodipine—Dizziness—Docetaxel—skin cancer	0.000188	0.00108	CcSEcCtD
Felodipine—Vomiting—Docetaxel—skin cancer	0.00018	0.00104	CcSEcCtD
Felodipine—Rash—Docetaxel—skin cancer	0.000179	0.00103	CcSEcCtD
Felodipine—Dermatitis—Docetaxel—skin cancer	0.000179	0.00103	CcSEcCtD
Felodipine—Headache—Docetaxel—skin cancer	0.000178	0.00102	CcSEcCtD
Felodipine—Nausea—Docetaxel—skin cancer	0.000169	0.000968	CcSEcCtD
Felodipine—ABCB1—lymph node—skin cancer	0.000149	0.00123	CbGeAlD
Felodipine—CALM3—Signaling by EGFR—IL6—skin cancer	2.72e-05	0.000254	CbGpPWpGaD
Felodipine—CALM1—Signaling by PDGF—HRAS—skin cancer	2.71e-05	0.000253	CbGpPWpGaD
Felodipine—CALM2—Signaling by PDGF—HRAS—skin cancer	2.71e-05	0.000253	CbGpPWpGaD
Felodipine—CALM3—Signaling by EGFR in Cancer—IL6—skin cancer	2.69e-05	0.000251	CbGpPWpGaD
Felodipine—PDE1B—Innate Immune System—IL6—skin cancer	2.68e-05	0.000251	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—SUFU—skin cancer	2.68e-05	0.00025	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—SUFU—skin cancer	2.68e-05	0.00025	CbGpPWpGaD
Felodipine—CALM3—Signaling by PDGF—IL6—skin cancer	2.68e-05	0.00025	CbGpPWpGaD
Felodipine—PDE1A—Signaling by GPCR—NRAS—skin cancer	2.67e-05	0.00025	CbGpPWpGaD
Felodipine—CALM3—Signaling by NGF—NRAS—skin cancer	2.67e-05	0.000249	CbGpPWpGaD
Felodipine—CALM3—Immune System—FOXO4—skin cancer	2.66e-05	0.000249	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—CSPG4—skin cancer	2.65e-05	0.000248	CbGpPWpGaD
Felodipine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	2.65e-05	0.000248	CbGpPWpGaD
Felodipine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	2.65e-05	0.000248	CbGpPWpGaD
Felodipine—CALM1—DAP12 interactions—IL6—skin cancer	2.65e-05	0.000248	CbGpPWpGaD
Felodipine—CALM1—Signaling by FGFR in disease—IL6—skin cancer	2.65e-05	0.000248	CbGpPWpGaD
Felodipine—CALM2—Signaling by FGFR in disease—IL6—skin cancer	2.65e-05	0.000248	CbGpPWpGaD
Felodipine—CALM2—DAP12 interactions—IL6—skin cancer	2.65e-05	0.000248	CbGpPWpGaD
Felodipine—PDE1B—Disease—PTGS2—skin cancer	2.65e-05	0.000248	CbGpPWpGaD
Felodipine—CALM3—B Cell Activation—HRAS—skin cancer	2.65e-05	0.000248	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—CSPG4—skin cancer	2.63e-05	0.000246	CbGpPWpGaD
Felodipine—CALM1—Signaling by EGFR—IL6—skin cancer	2.63e-05	0.000245	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR—IL6—skin cancer	2.63e-05	0.000245	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR in Cancer—IL6—skin cancer	2.6e-05	0.000243	CbGpPWpGaD
Felodipine—CALM1—Signaling by EGFR in Cancer—IL6—skin cancer	2.6e-05	0.000243	CbGpPWpGaD
Felodipine—CALM3—Transmission across Chemical Synapses—HRAS—skin cancer	2.6e-05	0.000243	CbGpPWpGaD
Felodipine—CALM2—Signaling by PDGF—IL6—skin cancer	2.59e-05	0.000242	CbGpPWpGaD
Felodipine—CALM1—Signaling by PDGF—IL6—skin cancer	2.59e-05	0.000242	CbGpPWpGaD
Felodipine—CALM2—Signaling by NGF—NRAS—skin cancer	2.58e-05	0.000241	CbGpPWpGaD
Felodipine—CALM1—Signaling by NGF—NRAS—skin cancer	2.58e-05	0.000241	CbGpPWpGaD
Felodipine—CALM2—Immune System—FOXO4—skin cancer	2.58e-05	0.000241	CbGpPWpGaD
Felodipine—CALM1—Immune System—FOXO4—skin cancer	2.58e-05	0.000241	CbGpPWpGaD
Felodipine—CALM1—B Cell Activation—HRAS—skin cancer	2.56e-05	0.000239	CbGpPWpGaD
Felodipine—CALM2—B Cell Activation—HRAS—skin cancer	2.56e-05	0.000239	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—ENO2—skin cancer	2.54e-05	0.000237	CbGpPWpGaD
Felodipine—CALM3—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.54e-05	0.000237	CbGpPWpGaD
Felodipine—CALM3—Metabolism—ENO2—skin cancer	2.53e-05	0.000236	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—BRAF—skin cancer	2.51e-05	0.000235	CbGpPWpGaD
Felodipine—CALM1—Transmission across Chemical Synapses—HRAS—skin cancer	2.51e-05	0.000235	CbGpPWpGaD
Felodipine—CALM2—Transmission across Chemical Synapses—HRAS—skin cancer	2.51e-05	0.000235	CbGpPWpGaD
Felodipine—CALM3—Disease—FOXO4—skin cancer	2.46e-05	0.00023	CbGpPWpGaD
Felodipine—CALM2—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.45e-05	0.000229	CbGpPWpGaD
Felodipine—CALM1—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.45e-05	0.000229	CbGpPWpGaD
Felodipine—PDE1B—Signaling by GPCR—NRAS—skin cancer	2.44e-05	0.000228	CbGpPWpGaD
Felodipine—CALM2—Metabolism—ENO2—skin cancer	2.44e-05	0.000228	CbGpPWpGaD
Felodipine—CALM1—Metabolism—ENO2—skin cancer	2.44e-05	0.000228	CbGpPWpGaD
Felodipine—PDE1A—Immune System—NRAS—skin cancer	2.44e-05	0.000228	CbGpPWpGaD
Felodipine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.43e-05	0.000227	CbGpPWpGaD
Felodipine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.4e-05	0.000224	CbGpPWpGaD
Felodipine—CACNB2—Metabolism—PTGS2—skin cancer	2.4e-05	0.000224	CbGpPWpGaD
Felodipine—CALM2—Disease—FOXO4—skin cancer	2.38e-05	0.000222	CbGpPWpGaD
Felodipine—CALM1—Disease—FOXO4—skin cancer	2.38e-05	0.000222	CbGpPWpGaD
Felodipine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.35e-05	0.000219	CbGpPWpGaD
Felodipine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.35e-05	0.000219	CbGpPWpGaD
Felodipine—PDE1A—Signaling by GPCR—KRAS—skin cancer	2.3e-05	0.000215	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—BRAF—skin cancer	2.3e-05	0.000215	CbGpPWpGaD
Felodipine—CALM3—Signaling by NGF—KRAS—skin cancer	2.29e-05	0.000214	CbGpPWpGaD
Felodipine—CACNA1D—Metabolism—PTGS2—skin cancer	2.27e-05	0.000212	CbGpPWpGaD
Felodipine—PDE1A—Disease—NRAS—skin cancer	2.25e-05	0.000211	CbGpPWpGaD
Felodipine—PDE1B—Immune System—NRAS—skin cancer	2.23e-05	0.000209	CbGpPWpGaD
Felodipine—CALM1—Signaling by NGF—KRAS—skin cancer	2.22e-05	0.000207	CbGpPWpGaD
Felodipine—CALM2—Signaling by NGF—KRAS—skin cancer	2.22e-05	0.000207	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—ENO2—skin cancer	2.2e-05	0.000205	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PLIN2—skin cancer	2.15e-05	0.000201	CbGpPWpGaD
Felodipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.13e-05	0.000199	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—SHH—skin cancer	2.11e-05	0.000197	CbGpPWpGaD
Felodipine—PDE1B—Signaling by GPCR—KRAS—skin cancer	2.1e-05	0.000197	CbGpPWpGaD
Felodipine—PDE1A—Immune System—KRAS—skin cancer	2.1e-05	0.000196	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—RASA1—skin cancer	2.1e-05	0.000196	CbGpPWpGaD
Felodipine—PDE1B—Disease—NRAS—skin cancer	2.06e-05	0.000193	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—SHH—skin cancer	2.04e-05	0.000191	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—SHH—skin cancer	2.04e-05	0.000191	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—ERCC2—skin cancer	2.04e-05	0.000191	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—RASA1—skin cancer	2.03e-05	0.00019	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—RASA1—skin cancer	2.03e-05	0.00019	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PTCH1—skin cancer	2e-05	0.000187	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—SMO—skin cancer	2e-05	0.000187	CbGpPWpGaD
Felodipine—CACNA1C—Metabolism—PTGS2—skin cancer	2e-05	0.000187	CbGpPWpGaD
Felodipine—CALM3—Neuronal System—HRAS—skin cancer	1.99e-05	0.000186	CbGpPWpGaD
Felodipine—PDE1A—Signaling by GPCR—HRAS—skin cancer	1.96e-05	0.000183	CbGpPWpGaD
Felodipine—CALM3—Signaling by NGF—HRAS—skin cancer	1.95e-05	0.000182	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PTGER4—skin cancer	1.95e-05	0.000182	CbGpPWpGaD
Felodipine—PDE1A—Disease—KRAS—skin cancer	1.94e-05	0.000181	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—SMO—skin cancer	1.94e-05	0.000181	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—SMO—skin cancer	1.94e-05	0.000181	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PTCH1—skin cancer	1.94e-05	0.000181	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PTCH1—skin cancer	1.94e-05	0.000181	CbGpPWpGaD
Felodipine—CALM2—Neuronal System—HRAS—skin cancer	1.92e-05	0.00018	CbGpPWpGaD
Felodipine—CALM1—Neuronal System—HRAS—skin cancer	1.92e-05	0.00018	CbGpPWpGaD
Felodipine—PDE1B—Immune System—KRAS—skin cancer	1.92e-05	0.00018	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—ENO2—skin cancer	1.91e-05	0.000179	CbGpPWpGaD
Felodipine—CALM1—Signaling by NGF—HRAS—skin cancer	1.89e-05	0.000176	CbGpPWpGaD
Felodipine—CALM2—Signaling by NGF—HRAS—skin cancer	1.89e-05	0.000176	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PTGER4—skin cancer	1.89e-05	0.000176	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PTGER4—skin cancer	1.89e-05	0.000176	CbGpPWpGaD
Felodipine—PDE1A—Signaling by GPCR—IL6—skin cancer	1.87e-05	0.000175	CbGpPWpGaD
Felodipine—CALM3—Signaling by NGF—IL6—skin cancer	1.87e-05	0.000174	CbGpPWpGaD
Felodipine—CALM2—Signaling by NGF—IL6—skin cancer	1.81e-05	0.000169	CbGpPWpGaD
Felodipine—CALM1—Signaling by NGF—IL6—skin cancer	1.81e-05	0.000169	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—ENO2—skin cancer	1.8e-05	0.000169	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—ENO2—skin cancer	1.79e-05	0.000167	CbGpPWpGaD
Felodipine—PDE1B—Signaling by GPCR—HRAS—skin cancer	1.79e-05	0.000167	CbGpPWpGaD
Felodipine—PDE1A—Immune System—HRAS—skin cancer	1.79e-05	0.000167	CbGpPWpGaD
Felodipine—PDE1B—Disease—KRAS—skin cancer	1.77e-05	0.000166	CbGpPWpGaD
Felodipine—CALM3—Disease—ERCC2—skin cancer	1.75e-05	0.000164	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CSPG4—skin cancer	1.74e-05	0.000162	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—FOXO4—skin cancer	1.72e-05	0.000161	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.72e-05	0.000161	CbGpPWpGaD
Felodipine—PDE1B—Signaling by GPCR—IL6—skin cancer	1.71e-05	0.00016	CbGpPWpGaD
Felodipine—PDE1A—Immune System—IL6—skin cancer	1.71e-05	0.00016	CbGpPWpGaD
Felodipine—CALM2—Disease—ERCC2—skin cancer	1.7e-05	0.000158	CbGpPWpGaD
Felodipine—CALM1—Disease—ERCC2—skin cancer	1.7e-05	0.000158	CbGpPWpGaD
Felodipine—CALM3—Hemostasis—NRAS—skin cancer	1.69e-05	0.000158	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—FOXO4—skin cancer	1.67e-05	0.000156	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—FOXO4—skin cancer	1.67e-05	0.000156	CbGpPWpGaD
Felodipine—PDE1A—Disease—HRAS—skin cancer	1.65e-05	0.000154	CbGpPWpGaD
Felodipine—CALM3—Disease—TERT—skin cancer	1.64e-05	0.000153	CbGpPWpGaD
Felodipine—PDE1B—Immune System—HRAS—skin cancer	1.63e-05	0.000153	CbGpPWpGaD
Felodipine—CALM2—Hemostasis—NRAS—skin cancer	1.63e-05	0.000153	CbGpPWpGaD
Felodipine—CALM1—Hemostasis—NRAS—skin cancer	1.63e-05	0.000153	CbGpPWpGaD
Felodipine—CALM2—Disease—TERT—skin cancer	1.59e-05	0.000148	CbGpPWpGaD
Felodipine—CALM1—Disease—TERT—skin cancer	1.59e-05	0.000148	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—NRAS—skin cancer	1.58e-05	0.000148	CbGpPWpGaD
Felodipine—PDE1A—Disease—IL6—skin cancer	1.58e-05	0.000147	CbGpPWpGaD
Felodipine—PDE1B—Immune System—IL6—skin cancer	1.56e-05	0.000146	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—NRAS—skin cancer	1.52e-05	0.000142	CbGpPWpGaD
Felodipine—PDE1B—Disease—HRAS—skin cancer	1.51e-05	0.000141	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—ERCC2—skin cancer	1.47e-05	0.000138	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—NRAS—skin cancer	1.47e-05	0.000137	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—NRAS—skin cancer	1.47e-05	0.000137	CbGpPWpGaD
Felodipine—CALM3—Metabolism—ERCC2—skin cancer	1.47e-05	0.000137	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—NRAS—skin cancer	1.46e-05	0.000136	CbGpPWpGaD
Felodipine—CALM3—Hemostasis—KRAS—skin cancer	1.45e-05	0.000136	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—NRAS—skin cancer	1.44e-05	0.000135	CbGpPWpGaD
Felodipine—PDE1B—Disease—IL6—skin cancer	1.44e-05	0.000135	CbGpPWpGaD
Felodipine—CALM1—Metabolism—ERCC2—skin cancer	1.42e-05	0.000133	CbGpPWpGaD
Felodipine—CALM2—Metabolism—ERCC2—skin cancer	1.42e-05	0.000133	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—NRAS—skin cancer	1.41e-05	0.000132	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—NRAS—skin cancer	1.41e-05	0.000132	CbGpPWpGaD
Felodipine—CALM1—Hemostasis—KRAS—skin cancer	1.41e-05	0.000131	CbGpPWpGaD
Felodipine—CALM2—Hemostasis—KRAS—skin cancer	1.41e-05	0.000131	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.4e-05	0.000131	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—KRAS—skin cancer	1.36e-05	0.000127	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—KRAS—skin cancer	1.31e-05	0.000122	CbGpPWpGaD
Felodipine—CALM3—Disease—BRAF—skin cancer	1.3e-05	0.000122	CbGpPWpGaD
Felodipine—CALM3—Hemostasis—TP53—skin cancer	1.29e-05	0.000121	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—ERCC2—skin cancer	1.28e-05	0.000119	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—KRAS—skin cancer	1.27e-05	0.000118	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—KRAS—skin cancer	1.27e-05	0.000118	CbGpPWpGaD
Felodipine—CALM2—Disease—BRAF—skin cancer	1.26e-05	0.000118	CbGpPWpGaD
Felodipine—CALM1—Disease—BRAF—skin cancer	1.26e-05	0.000118	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—KRAS—skin cancer	1.26e-05	0.000117	CbGpPWpGaD
Felodipine—CALM2—Hemostasis—TP53—skin cancer	1.25e-05	0.000117	CbGpPWpGaD
Felodipine—CALM1—Hemostasis—TP53—skin cancer	1.25e-05	0.000117	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—KRAS—skin cancer	1.24e-05	0.000116	CbGpPWpGaD
Felodipine—CALM3—Hemostasis—HRAS—skin cancer	1.24e-05	0.000115	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—PTGS2—skin cancer	1.22e-05	0.000114	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—KRAS—skin cancer	1.22e-05	0.000114	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—KRAS—skin cancer	1.22e-05	0.000114	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—TP53—skin cancer	1.21e-05	0.000113	CbGpPWpGaD
Felodipine—CALM2—Hemostasis—HRAS—skin cancer	1.19e-05	0.000112	CbGpPWpGaD
Felodipine—CALM1—Hemostasis—HRAS—skin cancer	1.19e-05	0.000112	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ENO2—skin cancer	1.18e-05	0.00011	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—HRAS—skin cancer	1.15e-05	0.000108	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TERT—skin cancer	1.15e-05	0.000107	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TERT—skin cancer	1.11e-05	0.000104	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TERT—skin cancer	1.11e-05	0.000104	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—HRAS—skin cancer	1.11e-05	0.000104	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—ERCC2—skin cancer	1.11e-05	0.000104	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—IL6—skin cancer	1.11e-05	0.000103	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—TP53—skin cancer	1.1e-05	0.000103	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—HRAS—skin cancer	1.08e-05	0.000101	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—HRAS—skin cancer	1.08e-05	0.000101	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—HRAS—skin cancer	1.07e-05	9.98e-05	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—IL6—skin cancer	1.06e-05	9.95e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—HRAS—skin cancer	1.06e-05	9.87e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—PTGS2—skin cancer	1.05e-05	9.82e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—ERCC2—skin cancer	1.05e-05	9.79e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—ERCC2—skin cancer	1.04e-05	9.71e-05	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—HRAS—skin cancer	1.03e-05	9.65e-05	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—HRAS—skin cancer	1.03e-05	9.65e-05	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—IL6—skin cancer	1.03e-05	9.62e-05	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—IL6—skin cancer	1.03e-05	9.62e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—PTGS2—skin cancer	1.02e-05	9.5e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—PTGS2—skin cancer	1.02e-05	9.5e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—IL6—skin cancer	1.01e-05	9.45e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—NRAS—skin cancer	9.69e-06	9.06e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—NRAS—skin cancer	9.37e-06	8.76e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—NRAS—skin cancer	9.37e-06	8.76e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—BRAF—skin cancer	9.11e-06	8.51e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—NRAS—skin cancer	8.85e-06	8.27e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PTGS2—skin cancer	8.84e-06	8.26e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—BRAF—skin cancer	8.81e-06	8.23e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—BRAF—skin cancer	8.81e-06	8.23e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PTGS2—skin cancer	8.8e-06	8.22e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—NRAS—skin cancer	8.57e-06	8e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—NRAS—skin cancer	8.57e-06	8e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PTGS2—skin cancer	8.51e-06	7.95e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PTGS2—skin cancer	8.51e-06	7.95e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—KRAS—skin cancer	8.34e-06	7.79e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—NRAS—skin cancer	8.17e-06	7.64e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—KRAS—skin cancer	8.07e-06	7.54e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—KRAS—skin cancer	8.07e-06	7.54e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—NRAS—skin cancer	7.91e-06	7.39e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—NRAS—skin cancer	7.91e-06	7.39e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PTGS2—skin cancer	7.65e-06	7.15e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—KRAS—skin cancer	7.62e-06	7.12e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—KRAS—skin cancer	7.37e-06	6.89e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—KRAS—skin cancer	7.37e-06	6.89e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—HRAS—skin cancer	7.09e-06	6.62e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—KRAS—skin cancer	7.04e-06	6.57e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—HRAS—skin cancer	6.86e-06	6.41e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—HRAS—skin cancer	6.86e-06	6.41e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ERCC2—skin cancer	6.85e-06	6.4e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—KRAS—skin cancer	6.81e-06	6.36e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—KRAS—skin cancer	6.81e-06	6.36e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—IL6—skin cancer	6.79e-06	6.34e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PTGS2—skin cancer	6.67e-06	6.23e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—IL6—skin cancer	6.56e-06	6.13e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—IL6—skin cancer	6.56e-06	6.13e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—HRAS—skin cancer	6.48e-06	6.05e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PTGS2—skin cancer	6.28e-06	5.87e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—HRAS—skin cancer	6.27e-06	5.86e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—HRAS—skin cancer	6.27e-06	5.86e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PTGS2—skin cancer	6.23e-06	5.82e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—IL6—skin cancer	6.2e-06	5.79e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—IL6—skin cancer	6e-06	5.6e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—IL6—skin cancer	6e-06	5.6e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—HRAS—skin cancer	5.98e-06	5.59e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—HRAS—skin cancer	5.79e-06	5.41e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—HRAS—skin cancer	5.79e-06	5.41e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—NRAS—skin cancer	5.72e-06	5.35e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—IL6—skin cancer	5.72e-06	5.35e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—NRAS—skin cancer	5.54e-06	5.17e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—NRAS—skin cancer	5.54e-06	5.17e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—IL6—skin cancer	5.54e-06	5.17e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—IL6—skin cancer	5.54e-06	5.17e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—KRAS—skin cancer	4.93e-06	4.6e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—KRAS—skin cancer	4.77e-06	4.45e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—KRAS—skin cancer	4.77e-06	4.45e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TP53—skin cancer	4.38e-06	4.09e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TP53—skin cancer	4.24e-06	3.96e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TP53—skin cancer	4.24e-06	3.96e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—HRAS—skin cancer	4.19e-06	3.91e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PTGS2—skin cancer	4.11e-06	3.84e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—HRAS—skin cancer	4.05e-06	3.79e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—HRAS—skin cancer	4.05e-06	3.79e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—IL6—skin cancer	4.01e-06	3.75e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL6—skin cancer	3.88e-06	3.62e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL6—skin cancer	3.88e-06	3.62e-05	CbGpPWpGaD
